Aditxt, Inc. Conversion of Stock, Amount Issued
Aditxt, Inc. (ADTX) reported Conversion of Stock, Amount Issued of $20.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountIssued1 · last filed 2026-05-20
- Aditxt, Inc. conversion of stock, amount issued for the quarter ending 2026-03-31 was $20.00M.
- Aditxt, Inc. conversion of stock, amount issued for the quarter ending 2024-12-31 was $5.33M.
- Aditxt, Inc. conversion of stock, amount issued for the quarter ending 2024-09-30 was $167.00K.
- Aditxt, Inc. conversion of stock, amount issued for fiscal 2024 was $6.00M.
| Period end | Conversion of Stock, Amount Issued 0 month | Conversion of Stock, Amount Issued 3 month | Conversion of Stock, Amount Issued 6 month | Conversion of Stock, Amount Issued 9 month | Conversion of Stock, Amount Issued 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $20.00M 10-Q · filed 2026-05-20 | ||||
| 2024-12-31 | $5.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.50M derived: sum of 2 quarters · filed 2026-03-31 | $6.00M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | $667.00K 10-Q · filed 2025-11-18 | |||
| 2024-06-30 | $500.00K 10-Q · filed 2025-08-14 | ||||
| 2023-10-05 | $3.87M 10-K · filed 2024-04-16 | ||||
| 2019-09-30 | $201.60K 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |